Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)Grazia Daniela Femminella, Paul Edison, Eleni Frangou et al.|Trials|2019Cited by 214
Evaluation of liraglutide in the treatment of Alzheimer's diseasePaul Edison, Clive Ballard, Grazia Daniela Femminella et al.|Alzheimer s & Dementia|2021Cited by 72
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?Grazia Daniela Femminella, Paul Edison, Nicholas R Livingston et al.|Alzheimer s Research & Therapy|2021Cited by 59
Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trialPaul Edison, Clive Ballard, Grazia Daniela Femminella et al.|Nature Medicine|2025Cited by 41
A roadmap to develop dementia research capacity and capability in Pakistan: A model for low‐ and middle‐income countriesIracema Leroi, Mohammad Wasay, Ambily Sathish et al.|Alzheimer s & Dementia Translational Research & Clinical Interventions|2019Cited by 20